首页> 外国专利> USE OF IMIDAZOL1,2-APYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA

USE OF IMIDAZOL1,2-APYRIDINE-3-ACETAMIDE DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF NEUROPSYCHIATRIC SYNDROMES ASSOCIATED WITH DISFUNCTION OF THE NEURAL CIRCUITS OF THE BASAL GANGLIA

机译:咪唑[1,2-A]嘧啶-3-乙酰胺衍生物在神经节突神经节功能失调伴发神经痛性综合征的治疗中的应用

摘要

The invention discloses the use of imidazol¢1,2-a!pyridine-3-acetamide derivatives to produce a drug for the treatment of Parkinson's disease, parkinsonian syndromes, other extrapyramidal syndromes such as those classified under the heading of "parkinsonism plus" (Steele-Richardson-Olszewski syndrome, cortical-basal ganglionic degeneration, multi-system atrophy, Wilson's disease, Hallervorden-Spatz disease, Huntington's disease, neuroacanthocytosis), obsessive-compulsive disorders and other obsessivecompulsive syndromes, frontal and subcortical dementias.
机译:本发明公开了咪唑ida1,2-α!吡啶-3-乙酰胺衍生物在生产用于治疗帕金森氏病,帕金森氏综合症,其他锥体外系综合症例如归类为“帕金森氏症加”( Steele-Richardson-Olszewski综合征,皮质基底神经节变性,多系统萎缩,威尔逊氏病,Hallervorden-Spatz病,亨廷顿氏病,神经棘皮细胞增多症,强迫症和其他强迫症,额叶和皮层下痴呆。

著录项

  • 公开/公告号CA2217590A1

    专利类型

  • 公开/公告日1996-10-10

    原文格式PDF

  • 申请/专利权人 CLARENDON-TRADING & INVESTIMENTOS LDA;

    申请/专利号CA19962217590

  • 发明设计人 BENINCASA ELENA;

    申请日1996-04-02

  • 分类号A61K31/44;A61K31/415;

  • 国家 CA

  • 入库时间 2022-08-22 03:50:12

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号